Who Is Considered
International societies consider metabolic surgery for patients with a BMI of 35 and above and type 2 diabetes, and for selected patients with BMI 30–34.9 in whom medical therapy and lifestyle changes have not achieved adequate control. Individual assessment by an endocrinologist and surgeon is essential.
Expected Effects
Many patients experience meaningful improvement in blood glucose, often early after surgery, with reduced need for medication. Complete and lasting remission is not guaranteed and depends on diabetes duration, beta-cell reserve, weight outcomes, and adherence to follow-up.
Risks and Trade-Offs
As with any surgery, metabolic procedures carry risks: bleeding, infection, leak, nutritional deficiencies and, in some patients, hypoglycaemia. These risks are discussed in detail before any decision.
Long-Term Follow-Up
Lifelong monitoring of HbA1c, micronutrients, and weight is part of the treatment, not optional. Patients who continue with their endocrinology and bariatric team usually maintain better metabolic outcomes.
References
- ADA — Standards of Medical Care in Diabetes (Obesity section)
- IFSO/ASMBS Indications for Metabolic and Bariatric Surgery, 2022
Last updated: 28.06.2026 · Medical content: Op.Dr.Gökhan ATEŞ